Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is an increase over the number of companies cited in the previous year.
The citations in the county include:
- The design history file was not established.
- Document control procedures have not been adequately established and maintained.
- Procedures to ensure that all purchased or otherwise received product and services conform to specified requirements have not been adequately established.
The company cited had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
NeuroField, Inc. | Devices | 06/23/2023 | Design history file |
NeuroField, Inc. | Devices | 06/23/2023 | Procedures not adequately established or maintained |
NeuroField, Inc. | Devices | 06/23/2023 | Purchasing controls, Lack of or inadequate procedures |
NeuroField, Inc. | Devices | 06/23/2023 | Software validation for automated processes |
NeuroField, Inc. | Devices | 06/23/2023 | Nonconforming product, Lack of or inadequate procedures |
NeuroField, Inc. | Devices | 06/23/2023 | Lack of or inadequate procedures |